Furthermore, both squamous cell carcinoma antigen (SCC-Ag) and neurite growth-promoting factor 2 (Midkine) have been suggested as independent prognostic factors for patients with SCCHN [21, 22]. This evidence concerns the gene MDK and head and neck squamous cell carcinoma.